Joseph Douglas Lyon - Jun 6, 2023 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Chief Accounting Officer
Signature
/s/ Joseph Douglas Lyon.
Stock symbol
CORT
Transactions as of
Jun 6, 2023
Transactions value $
-$122,500
Form type
4
Date filed
6/7/2023, 09:17 PM
Previous filing
Jun 5, 2023
Next filing
Aug 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Options Exercise $114K +10K +194.86% $11.35 15.1K Jun 6, 2023 Direct F3
transaction CORT Common Stock Sale -$236K -10K -66.09% $23.60 5.13K Jun 6, 2023 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CORT Stock option (right to buy) Options Exercise $0 -10K -15.02% $0.00 56.6K Jun 6, 2023 Common Stock 10K $11.35 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were affected pursuant to Rule 144.
F2 Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $23.60 to $23.61. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
F3 Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023 and 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
F4 Fully exercisable.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.